These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG. Honorat JA; Lopez-Chiriboga AS; Kryzer TJ; Komorowski L; Scharf M; Hinson SR; Lennon VA; Pittock SJ; Klein CJ; McKeon A Neurology; 2019 Sep; 93(10):e954-e963. PubMed ID: 31371564 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against eukaryotic translation elongation factor 1 delta in two patients with autoimmune cerebellar ataxia. Guo L; Ren H; Fan S; Chao X; Liu M; Guan H; Wang J Front Immunol; 2023; 14():1289175. PubMed ID: 38332912 [TBL] [Abstract][Full Text] [Related]
11. Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis. Hahn S; Trendelenburg G; Scharf M; Denno Y; Brakopp S; Teegen B; Probst C; Wandinger KP; Buttmann M; Haarmann A; Szabados F; Vom Dahl M; Kümpfel T; Eichhorn P; Gold H; Paul F; Jarius S; Melzer N; Stöcker W; Komorowski L J Neuroinflammation; 2017 Jun; 14(1):123. PubMed ID: 28645295 [TBL] [Abstract][Full Text] [Related]
12. Identification of DAGLA as an autoantibody target in cerebellar ataxia. Miske R; Scharf M; Borowski K; Specht I; Corty M; Loritz MJ; Rombach F; Laureys G; Rochow N; Radzimski C; Schnitter L; Ratuszny D; Skripuletz T; Wattjes MP; Hahn S; Denno Y; Guerti K; Oyaert M; Benkhadra F; Bien CI; Nitsch S; Wandinger KP; van Pesch V; Probst C; Teegen B; Komorowski L; Sühs KW J Neurol Neurosurg Psychiatry; 2024 Apr; ():. PubMed ID: 38663995 [TBL] [Abstract][Full Text] [Related]
13. Case Report: Alzheimer's Dementia Associated With Cerebrospinal Fluid Neurochondrin Autoantibodies. Hansen N; Malchow B; Teegen B; Wiltfang J; Bartels C Front Neurol; 2022; 13():879009. PubMed ID: 35785337 [TBL] [Abstract][Full Text] [Related]
14. Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration. Probst C; Komorowski L; de Graaff E; van Coevorden-Hameete M; Rogemond V; Honnorat J; Sabeter L; Graus F; Jarius S; Voltz R; Wildemann B; Franciotta D; Blöcker IM; Schlumberger W; Stöcker W; Sillevis Smitt PA Neurol Neuroimmunol Neuroinflamm; 2015 Apr; 2(2):e68. PubMed ID: 25745634 [TBL] [Abstract][Full Text] [Related]
15. Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia. Garza M; Piquet AL Front Neurol; 2021; 12():683048. PubMed ID: 34489848 [TBL] [Abstract][Full Text] [Related]
16. Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia. Jarius S; Scharf M; Begemann N; Stöcker W; Probst C; Serysheva II; Nagel S; Graus F; Psimaras D; Wildemann B; Komorowski L J Neuroinflammation; 2014 Dec; 11():206. PubMed ID: 25498830 [TBL] [Abstract][Full Text] [Related]
17. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C. Probst C; Radzimski C; Blöcker IM; Teegen B; Bogdanos DP; Stöcker W; Komorowski L Clin Chim Acta; 2013 Mar; 418():91-6. PubMed ID: 23333419 [TBL] [Abstract][Full Text] [Related]
18. Autoimmune septin-5 cerebellar ataxia. Honorat JA; Lopez-Chiriboga AS; Kryzer TJ; Fryer JP; Devine M; Flores A; Lennon VA; Pittock SJ; McKeon A Neurol Neuroimmunol Neuroinflamm; 2018 Sep; 5(5):e474. PubMed ID: 29998156 [TBL] [Abstract][Full Text] [Related]